APP and Alzheimer disease: To further characterize the possible role of S100A6 upregulation in the AD brain, we co-incubated COS-7 cells overexpressing hS100A6 with, or added recombinant hS100A6 protein to, unfixed Aβ-rich brain sections from aged APP/PS1 transgenic mice.